Effect of Anti-Tubercular Therapy Duration (6 Months versus ≥9-Months) on Treatment Outcomes in Serpiginous-Like Choroiditis: A Multicenter Retrospective Observational Study

This study aimed to determine the impact of the duration of anti-tubercular therapy (ATT) on treatment outcomes in patients with Serpiginous-Like Choroiditis, comparing 6 months versus 9 months or more of treatment. The findings revealed no significant differences in recurrence rates, persistence of inflammation, or changes in visual acuity between the two treatment durations. Additionally, the study noted instances of systemic toxicity and ethambutol-induced optic neuropathy, but these did not correlate with the duration of ATT.